Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HECW1 intronic transcript 1 (HECW1-IT1) is a non-protein coding RNA (long non-coding RNA) transcribed from intronic sequences within the HECW1 gene locus. There is no robust evidence that HECW1-IT1 acts as a canonical therapeutic target, such as a receptor, enzyme, transporter, or other druggable protein. Instead, it may have regulatory or non-coding functions typical of other intronic and long non-coding RNAs, but specific biological effects, disease roles, or direct therapeutic targeting information for HECW1-IT1 are currently lacking in scientific literature.\n\nEssential clarification:\n- HECW1 (HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1, also known as NEDL1) is a protein-coding gene that encodes an E3 ubiquitin ligase involved in ubiquitin-mediated proteolysis, and is sometimes investigated as a target due to its role in protein turnover and cell signaling pathways[1][2][3].\n- However, HECW1 "intronic transcript 1" (HECW1-IT1) refers specifically to a *non-protein coding* transcript from the introns of the HECW1 gene and does not encode a functional protein[3].\n- No evidence currently supports HECW1-IT1 as a therapeutic target, or as having established roles in disease, drug interaction, or as a clinical biomarker.\n- If protein-coding HECW1 was intended, please clarify and resubmit the query for data relating to the E3 ubiquitin ligase. If searching for non-coding RNA function or disease association for HECW1-IT1, current knowledge is limited and there are no established clinical or biological roles described in the primary literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HECW1 intronic transcript 1 (non-protein coding) (HECW1-IT1).